Monitoring on Truncation of AMCase Treated With shRNA

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-A-068-Tuesday
• By: LIU, Chao-Lin (MINGCHI UNIVERSITY OF TECHNOLOGY, Taipei, China Taiwan)
• Co-author(s): Chao-Lin Liu: Department of Chemical Engineering, Ming Chi University of Technology, New Taipei, Taiwan, Province of China
  Hsi-Jien Chen: Department of Safety, Health and Environmental Engineering, Ming Chi University of Technology, New Taipei, Taiwan, Province of China
  Yung-Hsian Wang: Department of Chemical Engineering, Ming Chi University of Technology, New Taipei, Taiwan, Province of China
  Chyau-Song Wu: Department of Chemical Engineering, Ming Chi University of Technology, New Taipei, Taiwan, Province of China
  Ching-Jen Yang: Development Center for Biotechnology, New Taipei, Taiwan, Province of China
  
• Abstract:

  Backgrounds

  The prevalence of asthma increases recently. The more develops, the more prevails. Most of the injuries for the asthma are irreversible. Now, the common therapy on asthma is bronchodilator agents. Recently, the syndrome can be improved when the AMCase blocked. The inhibitors of AMCase are chemicals or small interfering RNA (siRNA).

  
  

  SiRNA

  
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login